Abnormal Liver Function Tests as Predictors of Adverse Maternal Outcomes in Women With Preeclampsia

Journal of Obstetrics and Gynaecology Canada

Volumn 33, Issue 10, 2011, Pages 995-1004

  Kozic, Jennifer R ^a   Benton, Samantha J ^a   Hutcheon, Jennifer A ^a   Payne, Beth A ^a   Magee, Laura A ^a   von Dadelszen, Peter ^a   Ansermino, J Mark ^b   Côté, Anne Marie ^b   Cundiff, Geoff ^b   Gruslin, Andrée ^b   Hugo, Dany ^b   Joseph, K S ^b   Lalji, Sayrin ^b   Lee, Shoo K ^b   Li, Jing ^b   Lott, Paula ^b   Menzies, Jennifer ^b   Moutquin, Jean Marie ^b   Ouellet, Annie B ^b   Russell, James A ^b   Shaw, Dorothy ^b   Smith, Graeme N ^b   Still, D Keith ^b   Tawagi, George ^b   Wagner, Brenda ^b   Walters, Barry N ^b   Mahajan, Swati ^b   Noovao, Amanda ^b   Kyle, Phillipa M ^b   Moore, M Peter ^b   Hall, David ^b   Wilhelm Steyn, D ^b   Biryabarema, Christine ^b   Mirembe, Florence ^b   Nakimuli, Annettee ^b   Pipkin, Fiona Broughton ^b   Loughna, Pamela ^b   Walker, James J ^b   Grobman, William ^b   Tsigas, Eleni ^b   Merialdi, Mario ^b   Widmer, Mariana ^b   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE   (United States)

Author keywords

Liver function tests; Maternal adverse outcomes; Preeclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; LACTATE DEHYDROGENASE; SERUM ALBUMIN;

ADULT; ADVERSE OUTCOME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PREDICTION; PREECLAMPSIA; PREGNANCY OUTCOME; PROSPECTIVE STUDY; BLOOD; CLINICAL TRIAL; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREGNANCY;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; COHORT STUDIES; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LIVER FUNCTION TESTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 84856640746     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35048-4     Document Type: Article

References (24)

1. Steegers E.A., von Dadelszen P., Duvvekot J.J., Pijnenborg R. Preeclampsia. Lancet. 2010, 376:631-644.
2. Magee L.A., Helewa M., Moutquin J.-M., von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Clinical Practice Guideline, No. 206, March 2008. J Obstet Gynaecol Can 2008, 30(Suppl 1):S1-S48.
3. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002, 99:159-167. ACOG Committee on Practice Bulletins-Obstetrics.
4. The management of severe preeclampsia/eclampsia. Green Top Guideline March 2006, 10(A). Royal College of Obstetricians and Gynaecologists, Available at: http://www.rcog.org.uk/files/rcog-corp/GTG10a230611.pdf. Accessed August 4, 2011.
5. von Dadelszen P., Payne B., Li J., Ansermino J.M., Broughton Pipkin F., Côté A.-M., et al. Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullPIERS model. Lancet 2011, 15:219-227.
6. Carpani G., Bozzo M., Ferazzi E., Pizzotti D., Radaelli T., Moroni G., et al. The evaluation of maternal parameters at diagnosis may predict HELLP syndrome severity. J Matern Fetal Neonat Med 2003, 13:147-151.
7. Magann E.F., Martin J.N. The laboratory evaluation of hypertensive gravidas. Obstet Gynecol Surv 1995, 50:138-145.
8. Demir S.C., Evruke C., Ozgunen F.T., Urunsak I.F., Candan E., Kadayifci O. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes and low platelet syndrome. Saudi Med J 2006, 27:1015-1018.
9. Hupuczi P., Nagy B., Sziller I., Rigó B., Hruby E., Papp Z. Characteristic laboratory changes in pregnancies complicated by HELLP syndrome. Hypertens Pregnancy 2007, 26:389-401.
10. Sibai B.M. Diagnosis, controversies and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004, 103:981-991.
11. von Dadelszen P., Magee L.A., Devarakonda R.M., Hamilton T., Ainsworth L.M., Yin R., et al. The predictors of adverse maternal outcomes in preeclampsia. J Obstet Gynaecol Can 2004, 26:871-879.
12. Magann E.F., Chauhan S.P., Naef R.W., Blake P.G., Morrison J.C., Martin J.N. Standard parameters of preeclampsia: can the clinician depend on them to reliably identify the patient with HELLP syndrome?. Aust N Z J Obstet Gynaecol 1993, 33:122-126.
13. Martin J.N., May W.L., Magann E.F., Terrone D.A., Rinehart B.K., Blake P.G. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999, 180:1407-1414.
14. Menzies J., Magee L.A., Li J., MacNab Y.C., Yin R., Stuart H., et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol 2007, 110:121-127.
15. von Dadelszen P., Sawchuck D., McMaster R., Douglas M.J., Lee S.K., Saunders S., et al. The active implementation of pregnancy hypertension guidelines in British Columbia. Obstet Gynecol 2010, 116:659-666.
16. Barton J.R., O'Brien J.M., Bergauer N.K., Jacques D.L., Sibai B.M. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001, 184:979-983.
17. Homer C.S., Brown M.A., Mangos G., Davis G.K. Non-proteinuric preeclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens 2008, 26:295-302.
18. Sibai B.M., Stella C.L. Diagnosis and management of atypical preeclampsiaeclampsia. Am J Obstet Gynecol 2009, 200:481e1-481e7.
19. Pre-eclamspia Integrated Estimate of RiSk (PIERS) [website]. University of British Columbia Child and Family Research Institute. Available at:. Accessed May 13, 2011. http://piers.cfri.ca.
20. Hutchinson A., Fowler P. Outcome measures for primary health-care- what are the research priorities?. Br J Gen Pract 1992, 42:227-231.
21. Martin J.N., Blake P.G., Lowry S.L., Perry J.C., Files J.C., Morrison J.C. Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery?. Obstet Gynecol 1990, 76:737-741.
22. Peralta Pedro M.L., Basavilvazo R., Cruz Avalar A., Sanchez Ambroz S., Guzman A., Martinez G. Clinical significance of the laboratory determinations of preeclamptic patients. Gynecologia y Obstetriciade 2004, 72:57-62.
23. Sibai B., Dekker G., Kupferminc M. Preeclampsia. Lancet 2005, 365:785-799.
24. Sibai B. Biomarkers for hypertension-preeclampsia: are we close yet?. Am J Obstet Gynecol 2007, 197:1-2.